New Product Watch

Premium

Fluidigm this week announced the availability of assays and target-specific primers for use with its integrated fluidic circuit technology. Using the assays and primers, customers can create highly multiplexed panels using catalog and custom content focused on their particular research area.

The products are being marketed as DeltaGene Assays for gene-expression profiling; SNPtype Assays for SNP genotyping; and Access Array Target-specific Primers for target enrichment prior to next-generation sequencing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.